Shots: VIVUS has accelerated the launch of the telemedicine and remote monitoring modules of the VIVUS Health Platform, will enable physicians to utilize it in conducting virtual office visits, regardless of whether the patient is prescribed a VIVUS product The company anticipates enrolling 150-200 physicians into the new modules each week. The VIVUS Health Platform […]Read More
OxThera’s Oxabact Receives EMA’s Positive Decision on Pediatric Investigational Plan to Treat Primary Hyperoxaluria Published: Aug 23, 2019 | Tags: OxThera, Oxabact, Receives, EMA, Positive Decision, Pediatric Investigational Plan, Treat, Primary Hyperoxaluria 2.Novartis Signs an Option Agreement with Iconic Therapeutics for its Ophthalmology Program Published: Aug 22, 2019 | Tags: Novartis, Signs, Option Agreement, Iconic Therapeutics, Ophthalmology […]Read More
Shots: The pilot clinical study involves assessing of Qsymia (phentermine and topiramate ER caps) in 25 patients with a BMI of 50+ who were planning to undergo LSG vs patients undergoing surgery alone without anti-obesity medication (AOM) The clinical study results: @24mos. BMI (33.8 kg/m2 vs 42 kg/m2); average wt. loss (28.1 kg vs 12.3 […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
